It would probably be good to touch on:
- To what degree we can attribute these results to Bisantrene (over Clofarabine and Fludarabine).
- Comparison response rates seen in other anti-cancer P2 drugs that go on to get picked up by BP
- Can we expect RC220 to have similar efficacy, or perhaps fewer adverse events (lower risk of infection)?
- Highlight the curious lack of cardiotoxicity despite Clofarabine being highly cardiotoxic!
- Any exploratory, or circumstantial FTO insights - pretty please
- Try to include some $$$ numbers - this needs to appeal to all investors, not just the altruistic
- Forums
- ASX - By Stock
- ASH2023 - Sheba 2.0
It would probably be good to touch on:To what degree we can...
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.48 |
Change
0.045(3.14%) |
Mkt cap ! $248.8M |
Open | High | Low | Value | Volume |
$1.42 | $1.48 | $1.41 | $74.60K | 51.49K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6944 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.48 | 3096 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6944 | 1.440 |
1 | 3196 | 1.430 |
1 | 650 | 1.425 |
1 | 360 | 1.415 |
1 | 3570 | 1.400 |
Price($) | Vol. | No. |
---|---|---|
1.480 | 3096 | 2 |
1.490 | 3500 | 1 |
1.495 | 3344 | 1 |
1.500 | 24302 | 3 |
1.520 | 4027 | 1 |
Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.47 |
  |
Change
0.045 ( 1.69 %) |
|||
Open | High | Low | Volume | ||
$1.41 | $1.48 | $1.41 | 21844 | ||
Last updated 15.59pm 31/05/2024 ? |
Featured News
RAC (ASX) Chart |